Nisa Investment Advisors
OLMA icon

Nisa Investment Advisors’s Olema Pharmaceuticals OLMA Stock Holding History

Nisa Investment Advisors’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$87.4K Buy
5,864
+2,100
+56% +$46.7K ﹤0.01% 1474
2025
Q4 		$94.1K Buy
3,764
+477
+15% +$8.49K ﹤0.01% 1455
2025
Q3 		$32.2K Buy
3,287
+72
+2% +$432 ﹤0.01% 1783
2025
Q2 		$13.7K Buy
+3,215
New +$14.3K ﹤0.01% 2112
2025
Q1 		– Sell
-86
Closed -$501 – 3041
2024
Q4 		$501 Buy
86
+12
+16% +$120 ﹤0.01% 2832
2024
Q3 		$884 Buy
74
+16
+28% +$205 ﹤0.01% 2608
2024
Q2 		$628 Buy
58
+51
+729% +$553 ﹤0.01% 2636
2024
Q1 		$79 Sell
7
-33
-83% -$426 ﹤0.01% 2729
2023
Q4 		$561 Buy
+40
New +$537 ﹤0.01% 2384
2022
Q2 		– Sell
-31,400
Closed -$134K – 2471
2022
Q1 		$134K Buy
+31,400
New +$173K ﹤0.01% 1522

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Nisa Investment Advisors's OLMA Position: Q1 2026 in Review

Nisa Investment Advisors increased its Olema Pharmaceuticals (OLMA) stake by 56% in Q1 2026, buying an estimated $46.7K and bringing the position to 5,864 shares worth $87.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1474.

Nisa Investment Advisors first reported a position in OLMA in Q1 2022 and has held it in 10 quarters since. The position peaked at $134K in Q1 2022. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Nisa Investment Advisors held 5,864 shares of Olema Pharmaceuticals worth $87.4K as of Q1 2026.
  • Nisa Investment Advisors bought 2,100 Olema Pharmaceuticals shares in Q1 2026, an estimated $46.7K.
  • Olema Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #1474 holding.
  • Nisa Investment Advisors first reported a position in Olema Pharmaceuticals in Q1 2022 and has held it in 10 quarters since.
  • Nisa Investment Advisors's Olema Pharmaceuticals position peaked at $134K in Q1 2022.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.